{"id":3021,"date":"2024-06-25T23:48:14","date_gmt":"2024-06-25T15:48:14","guid":{"rendered":"https:\/\/opentrons.com.cn\/?post_type=knowledge2&p=3021"},"modified":"2024-09-02T18:57:05","modified_gmt":"2024-09-02T10:57:05","slug":"syrnadvance-viralheot-2pt","status":"publish","type":"post","link":"https:\/\/opentrons.com.cn\/en\/news\/syrnadvance-viralheot-2pt\/","title":{"rendered":"Use RNAdvance Viral and OT-2 platforms to conduct efficient and high-throughput SARS-CoV-2 viral RNA detection and sequencing research"},"content":{"rendered":"\n
Application Introduction The 2020 COVID-19 pandemic has raged across the world, intensifying human demand for high-throughput RNA detection and gene sequencing for clinical research purposes. Traditional manual operation methods are difficult to improve the efficiency of RNA detection. In this study, we demonstrate an automated SARS-CoV-2 RNA extraction workflow using the Beckman Coulter Life Sciences RNAd-vance Viral Kit (C63510) on an Opentrons OT-2 automated pipetting workstation. We present analytical data showing limits of detection (LoD) for SARS-CoV-2 quantification by qRT-PCR and sequence alignment data that inform automated sequencing samples and library preparation for genetic characterization of mutant strains.<\/p>\n\n\n\n
Overview of the RNAdvance Viral Kit and OT-2 Platform The RNAdvance Viral kit efficiently extracts viral RNA from samples by utilizing SPRI paramagnetic bead technology. We used this reagent on an automated Opentrons platform from synthetic nasal matrix (110 mM NaCl, 1% w\/v porcine gastric type I mucus (Sigma M2378-100G) and 10 \u03bcg\/mL w\/v human genomic DNA (Coriell NA12878), 90% v\/v TE\/SNM) samples were extracted with different concentrations of heat-inactivated SARS-CoV-2(ATCC\u00b0VR-1986HKTM). Each concentration includes 20 test samples, 2 positive controls, and 2 negative controls.<\/p>\n\n\n\n
Workflow throughput Figure 1 shows the OT-2 deck layout for the automated RNAdvance virus extraction workflow. The workflow begins with the addition of Bind (BBB) \u200b\u200bto the sample lysate and consumes only 10 tips per sample, providing the flexibility to run up to 96 samples in 8 batch sizes. The workflow duration described in the report includes actual operation time, sample lysis time, and optimized sample run time (Figure 2). Using the RNAdvance Viral kit and OT-2 platform, the workflow for processing 96 samples takes a total of 3.5 hours. You can copy the link to the browser to view the specific protocol process: https:\/\/protocols.opentrons.com\/protocol\/bc- rnadvance-viral. You have the flexibility to change method variables based on your needs to get the desired results with your desired batch size, sample input, and elution volume.<\/p>\n\n\n\n